Uromems
UroMems is a medical device company developing smart active implantable technology to treat stress urinary incontinence in women and men.
Uromems has raised €126M across 5 funding rounds from 13 investors, most recently a Growth/Late round in May 2026. Based in Grenoble, France; founded 2011; active in Healthtech. Data as of 4 Nov 2026.
Total raised
€126M
€125,570,024
Funding rounds
5
Investors
13
distinct backers
Active since
2016-11
latest 2026-05
Funding by year
EUR raised per year · 2026 YTDUromems — funding by year — interactive chart.
Data table
| Uromems — funding by year | |
|---|---|
| 2016 | €14M |
| 2020 | €16M |
| 2024 | €44M |
| 2026 | €52M |
Signals
High confidenceRaise-next likelihood32
base rate 37% for Growth/Late
- ▼ Raised very recently
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood23
base rate 11% (2+ rounds)
- ▲ €100M+ raised
- ▲ 5 rounds raised
- ▲ Recently backed by strong-exit-track investors
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
5 rounds- 2026-05-15Growth/Late€52M
- 2024-06-26Series C€44M
- 2020-05-20Series B€16M
- 2016-11-01Grant€2.0M
- 2016-11-01Series A€12M
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-05-15 | Growth/Late | €52M | Ajax Health Fund I | View deal → |
| 2024-06-26 | Series C | €44M | btov Partners,Bpifrance,Crédit Mutuel Innovation,European Innovation Council,Financière Arbevel,Hil-Invent+2 more | View deal → |
| 2020-05-20 | Series B | €16M | Arbevel,Hil-Invest | View deal → |
| 2016-11-01 | Grant | €2.0M | — | View deal → |
| 2016-11-01 | Series A | €12M | btov Partners,Bpifrance,CEA Investissement,CITA Investissement,Wellington Partners | View deal → |